{'52WeekChange': 0.40833712,
 'SandP52WeekChange': 0.0644362,
 'address1': 'One Amgen Center Drive',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 249.95,
 'askSize': 3100,
 'averageDailyVolume10Day': 1857850,
 'averageVolume': 2726984,
 'averageVolume10days': 1857850,
 'beta': 0.946778,
 'beta3Year': None,
 'bid': 241.01,
 'bidSize': 800,
 'bookValue': 16.131,
 'category': None,
 'circulatingSupply': None,
 'city': 'Thousand Oaks',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 251.83,
 'dayLow': 245.5,
 'dividendRate': 6.4,
 'dividendYield': 0.0254,
 'earningsQuarterlyGrowth': -0.084,
 'enterpriseToEbitda': 14.302,
 'enterpriseToRevenue': 7.186,
 'enterpriseValue': 172215517184,
 'exDividendDate': 1589500800,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '805 447 1010',
 'fiftyDayAverage': 241.16885,
 'fiftyTwoWeekHigh': 264.97,
 'fiftyTwoWeekLow': 174.27,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': 2.53,
 'floatShares': 586912077,
 'forwardEps': 16.92,
 'forwardPE': 14.656028,
 'fromCurrency': None,
 'fullTimeEmployees': 23400,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.0022200001,
 'heldPercentInstitutions': 0.7893,
 'industry': 'Drug Manufacturers—General',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 943228800,
 'lastSplitFactor': '2:1',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/amgen.com',
 'longBusinessSummary': 'Amgen Inc. discovers, develops, manufactures, and '
                        'delivers human therapeutics worldwide. It focuses on '
                        'inflammation, oncology/hematology, bone health, '
                        'cardiovascular disease, nephrology and neuroscience '
                        "areas. The company's products include Enbrel to treat "
                        'plaque psoriasis, rheumatoid arthritis, and psoriatic '
                        'arthritis; Neulasta, a pegylated protein to treat '
                        'cancer patients; Prolia to treat postmenopausal women '
                        'with osteoporosis; Xgeva for skeletal-related events '
                        'prevention; Aranesp to treat a lower-than-normal '
                        'number of red blood cells and anemia; KYPROLIS to '
                        'treat patients with relapsed or refractory multiple '
                        'myeloma; Sensipar/Mimpara to treat secondary '
                        'hyperparathyroidism; and EPOGEN to treat anemia '
                        'caused by chronic kidney disease. It also markets '
                        'other products in various markets, including Nplate, '
                        'Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, '
                        'NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, '
                        'IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves '
                        'healthcare providers, including physicians or their '
                        'clinics, dialysis centers, hospitals, and pharmacies. '
                        'It distributes its products through pharmaceutical '
                        'wholesale distributors, as well as direct-to-consumer '
                        'channels. The company has collaboration agreements '
                        'with Novartis; UCB; Bayer HealthCare LLC; BeiGene, '
                        'Ltd.; QIAGEN N.V.; and Adaptive Biotechnologies. '
                        'Amgen Inc. was founded in 1980 and is headquartered '
                        'in Thousand Oaks, California.',
 'longName': 'Amgen Inc.',
 'market': 'us_market',
 'marketCap': 145873485824,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_24816',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 7674999808,
 'nextFiscalYearEnd': 1640908800,
 'open': 251.26,
 'openInterest': None,
 'payoutRatio': 0.4659,
 'pegRatio': 2.47,
 'phone': '805 447 1000',
 'previousClose': 252.24,
 'priceHint': 2,
 'priceToBook': 15.372884,
 'priceToSalesTrailing12Months': 6.0866847,
 'profitMargins': 0.32025,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 251.83,
 'regularMarketDayLow': 245.5,
 'regularMarketOpen': 251.26,
 'regularMarketPreviousClose': 252.24,
 'regularMarketPrice': 251.26,
 'regularMarketVolume': 2161800,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 588246976,
 'sharesPercentSharesOut': 0.010199999,
 'sharesShort': 6026675,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 6164116,
 'shortName': 'Amgen Inc.',
 'shortPercentOfFloat': 0.010299999,
 'shortRatio': 2.18,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'AMGN',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': 5.95,
 'trailingAnnualDividendYield': 0.023588644,
 'trailingEps': 12.773,
 'trailingPE': 19.41439,
 'twoHundredDayAverage': 226.7528,
 'volume': 2161800,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.amgen.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '91320-1799'}